Your browser doesn't support javascript.
loading
Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.
Furuichi, Kengo; Shimizu, Miho; Yamanouchi, Masayuki; Hoshino, Junichi; Sakai, Norihiko; Iwata, Yasunori; Toyama, Tadashi; Kitajima, Shinji; Hara, Akinori; Yuzawa, Yukio; Kitamura, Hiroshi; Suzuki, Yoshiki; Sato, Hiroshi; Uesugi, Noriko; Ueda, Yoshihiko; Nishi, Shinichi; Nishino, Tomoya; Samejima, Kenichi; Kohagura, Kentaro; Shibagaki, Yugo; Makino, Hirofumi; Matsuo, Seiichi; Ubara, Yoshifumi; Yokoyama, Hitoshi; Wada, Takashi.
Afiliación
  • Furuichi K; Department of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Japan furuichi@kanazawa-med.ac.jp.
  • Shimizu M; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Yamanouchi M; Nephrology Center, Toranomon Hospital, Tokyo, Japan.
  • Hoshino J; Nephrology Center, Toranomon Hospital, Tokyo, Japan.
  • Sakai N; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Iwata Y; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Toyama T; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Kitajima S; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Hara A; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Yuzawa Y; Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Kitamura H; Department of Pathology, Clinical Research Center, National Hospital Organization Chiba-East National Hospital, Chiba, Japan.
  • Suzuki Y; Health Administration Center, Niigata University, Niigata, Japan.
  • Sato H; Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan.
  • Uesugi N; Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Ueda Y; Department of Pathology, Dokkyo Medical University, Saitama Medical Center, Koshigaya, Japan.
  • Nishi S; Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Nishino T; Department of Nephrology, Nagasaki University Hospital, Nagasaki, Japan.
  • Samejima K; Department of Nephrology, Nara Medical University, Nara, Japan.
  • Kohagura K; Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus School of Medicine, Nakagami-gun, Okinawa, Japan.
  • Shibagaki Y; Division of Nephrology, Department of Internal Medicine, St. Marianna University, School of Medicine, Kawasaki, Japan.
  • Makino H; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Matsuo S; Division of Nephrology, Department of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ubara Y; Nephrology Center, Toranomon Hospital, Tokyo, Japan.
  • Yokoyama H; Department of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Japan.
  • Wada T; Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Article en En | MEDLINE | ID: mdl-32503809
ABSTRACT

INTRODUCTION:

The speed of declining kidney function differs among patients with diabetic nephropathy. This study was undertaken to clarify clinical and pathological features that affect the speed of declining kidney function in patients with diabetic nephropathy. RESEARCH DESIGN AND

METHODS:

This study was design as multicenter retrospective study. The subjects (377 patients with diabetic nephropathy diagnosed by kidney biopsy at 13 centers in Japan) were classified into three groups based on the estimated glomerular filtration rate (eGFR) declining speed. The eGFR increasing group, the control group, and the eGFR declining group were divided at 0 and 5 mL/min/1.73 m2/year, respectively. Characteristics of clinicopathological findings of declining kidney function were evaluated.

RESULTS:

The mean observation period of this study was 6.9 years. The control group, the eGFR increasing group, and the eGFR declining group included 81, 66, and 230 patients, respectively. The incidences of composite kidney events represented by 100 persons/year were 25.8 in the eGFR declining group and 2.0 in the eGFR increasing group. After adjustment for age, sex, systolic blood pressure, hemoglobin, and urinary albumin levels, three clinicopathological findings (urinary albumin levels, presence of nodular lesion, and mesangiolysis) were risk factors for inclusion in the eGFR declining group (the ORs were 1.49, 2.18, and 2.08, respectively). In contrast, the presence of subendothelial space widening and polar vasculosis were characteristic findings for inclusion in the eGFR increasing group (the ORs were 0.53 and 0.41, respectively).

CONCLUSIONS:

As well as urinary albumin elevation, nodular lesion and mesangiolysis were characteristic pathological features of patients with fast declining kidney function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: BMJ Open Diabetes Res Care Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: BMJ Open Diabetes Res Care Año: 2020 Tipo del documento: Article País de afiliación: Japón